OWC Pharmaceutical Research Corp (OWCP)

[Ortiz26]

Phase 1 results could be released at any time since they said the end of January, and we have a good feeling they will be very positive based on the recent letter. Markets react very well to big positive news like this.

Quotes from the letter, connect the dots:

"The results of our in-vitro testing indicated that specific formulations of the cannabinoids CBD and THC decreased the survival of multiple myeloma cells in a concentration-dependent manner, and resulted in a 100 percent malignant cell death in 60 percent of the infected mice.
With the success of its in-vitro mice study, OWCP has determined to proceed with a pre-clinical, Institutional Review Board approved protocol on mice to duplicate those results. It is hopeful that these further studies will provide the scientific justification for OWCP to proceed with human trials."

And Mr. Baruch's background:

"Dr. Yehuda Baruch is One World's Director of Research and is OWC's Chief Science Officer. Before joining OWC, Dr. Baruch was the head of the Israeli Ministry of Health's Medical Cannabis Program for ten years, where his responsibilities included overseeing the government's regulatory compliance, obtaining approvals for clinical trials from institutional review boards and overseeing patient cannabis approvals and dosage recommendations."